BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9368908)

  • 1. Anti-thrombotic and anti-inflammatory activities of protopine.
    Saeed SA; Gilani AH; Majoo RU; Shah BH
    Pharmacol Res; 1997 Jul; 36(1):1-7. PubMed ID: 9368908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual inhibition of platelet-activating factor and arachidonic acid metabolism by ajmaline and effect on carrageenan-induced rat paw oedema.
    Saeed SA; Simjee RU; Mahmood F; Rahman NN
    J Pharm Pharmacol; 1993 Aug; 45(8):715-9. PubMed ID: 7901369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of protopine on blood platelet aggregation. III. Effect of protopine on the metabolic system of arachidonic acid in platelets.
    Shiomoto H; Matsuda H; Kubo M
    Chem Pharm Bull (Tokyo); 1991 Feb; 39(2):474-7. PubMed ID: 1905202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of the Korean herbal medicine, Dae-Jo-Whan, on platelet-activating factor-induced platelet aggregation.
    Chang GT; Kang SK; Kim JH; Chung KH; Chang YC; Kim CH
    J Ethnopharmacol; 2005 Dec; 102(3):430-9. PubMed ID: 16125889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of protopine on rabbit platelet function].
    Ma GY; Zhang ZZ; Chen ZH
    Zhongguo Yao Li Xue Bao; 1994 Jul; 15(4):367-71. PubMed ID: 7801784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of protopine on cytosolic Ca2+ in rabbit platelets.
    Shen ZQ; Chen ZH; Duan L
    Zhongguo Yao Li Xue Bao; 1999 Apr; 20(4):338-40. PubMed ID: 10452120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet effects of protopine isolated from Corydalis tubers.
    Ko FN; Wu TS; Lu ST; Wu YC; Huang TF; Teng CM
    Thromb Res; 1989 Oct; 56(2):289-98. PubMed ID: 2559491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling.
    Shah BH; Nawaz Z; Pertani SA; Roomi A; Mahmood H; Saeed SA; Gilani AH
    Biochem Pharmacol; 1999 Oct; 58(7):1167-72. PubMed ID: 10484074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet aggregation activity of diterpene alkaloids from Spiraea japonica.
    Li L; Shen YM; Yang XS; Zuo GY; Shen ZQ; Chen ZH; Hao XJ
    Eur J Pharmacol; 2002 Aug; 449(1-2):23-8. PubMed ID: 12163102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production.
    Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC
    Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of protopine on blood platelet aggregation. II. Effect on metabolic system of adenosine 3',5'-cyclic monophosphate in platelets.
    Shiomoto H; Matsuda H; Kubo M
    Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2320-2. PubMed ID: 2177684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of collagen-induced platelet aggregation and adhesion by a pseudocyanide derivative of avicine isolated from Zanthoxylum integrifoliolum Merr.
    Ko FN; Hsiao G; Chen IS; Wu SJ; Teng CM
    Biochem Pharmacol; 1993 Oct; 46(7):1165-73. PubMed ID: 8216367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eugenol: a dual inhibitor of platelet-activating factor and arachidonic acid metabolism.
    Saeed SA; Simjee RU; Shamim G; Gilani AH
    Phytomedicine; 1995 Jul; 2(1):23-8. PubMed ID: 23196096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic activity of clove oil.
    Saeed SA; Gilani AH
    J Pak Med Assoc; 1994 May; 44(5):112-5. PubMed ID: 8078176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by glaucocalyxin A of aggregation of rabbit platelets induced by ADP, arachidonic acid and platelet-activating factor, and inhibition of [3H]-PAF binding.
    Bin Z; Kun L
    Thromb Haemost; 1992 Apr; 67(4):458-60. PubMed ID: 1631795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potent inhibition of vapiprost, a novel thromboxane A2 receptor antagonist, on the secondary aggregation and ATP release of human platelets.
    Horie S; Yamada M; Satoh M; Noritake S; Hiraishi S; Kizaki K; Kurusu O; Nakahara T; Ishii H; Kazama M
    Biol Pharm Bull; 1997 Jun; 20(6):625-31. PubMed ID: 9212979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ethanol on pathways of platelet aggregation in vitro.
    Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
    Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor (PAF) receptor antagonists inhibit arachidonic acid induced platelet aggregation in rabbit whole blood.
    Ammit AJ; O'Neill C
    Lipids; 1991 Dec; 26(12):1189-92. PubMed ID: 1668116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
    Porta C; Maiolo A; Tua A; Grignani G
    Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of plumbagin on platelet aggregation and platelet-neutrophil interactions.
    Shen Z; Dong Z; Cheng P; Li L; Chen Z; Liu J
    Planta Med; 2003 Jul; 69(7):605-9. PubMed ID: 12898414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.